Arovella Therapeutics
- Biotech or pharma, therapeutic R&D
Arovella Therapeutics Ltd (ASX: ALA) is a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform to treat various cancers.
June 16-19, 2025
Boston Convention & Exhibition Center
Arovella Therapeutics Ltd (ASX: ALA) is a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell therapy platform to treat various cancers.